Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Trump asks for bill to lower drug prices in State of the Union address

President Donald Trump gave his annual State of the Union address on Feb. 4, calling on Congress to take on sky-high prescription drug prices.

In Iowa caucuses, healthcare issue takes center stage

Healthcare was top of mind among Iowa caucus-goers as the start of the 2020 election kicked off in the state on Feb. 3. About 60% of Democrats at the Iowa caucuses said they support eliminating private health insurance and moving to a single-payer healthcare system.

Thumbnail

Coronavirus is deadly and expensive

The novel coronavirus, which originated in Wuhan, China, has become the world’s most expensive epidemic, according to data from Learnbonds.com. In fact, the virus, which has been compared to SARS and MERS, is expected to cost China about 2% of its GDP during the first quarter of 2020, or $62 billion.

 

Thumbnail

HIV vaccine fails trial in South Africa

An experimental vaccine to prevent HIV has proven ineffective in preventing the virus, according to a study conducted by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH).

Thumbnail

Former Aetna CEO cites ‘tension’ in CVS board changes

The former CEO of health insurer Aetna, which was acquired by CVS Health for $69 billion at the end of 2018, says he is being pushed off the board of the combined company.

 

Thumbnail

Trump admin’s Medicaid block grants met with industry backlash

Medicaid block grants, which have been framed as an “opportunity” for states to better control their Medicaid spending and gain flexibility, have been harshly criticized by healthcare groups.

Thumbnail

CVS Health makes board changes, drops three seats

CVS Health is changing up its board of directors, transitioning from 16 members to 13, according to an announcement. The move was “to further align with corporate governance best practices,” according to CVS.

Johnson & Johnson ordered to pay pelvic mesh settlement of $344M

Johnson & Johnson has been ordered to pay $344 million to settle lawsuits that the pharmaceutical and consumer packaged goods deceptively marketed its transvaginal mesh medical device product.

Displaying 2081 - 2088 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup